Markets:

Overview

News

Currencies

International

Treasuries

ACADIA Pharmaceuticals Inc. - Common Stock (NQ:ACAD)

22.47 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about ACADIA Pharmaceuticals Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Dow Dips Over 100 Points; Cocrystal Pharma Shares Slide ↗

December 31, 2024

Via Benzinga

Topics Stocks

Crude Oil Rises 1%; Sangamo Therapeutics Shares Plummet ↗

December 31, 2024

Via Benzinga

Acadia Pharmaceuticals, FTAI Aviation And Other Big Stocks Moving Higher On Tuesday ↗

December 31, 2024

Via Benzinga

Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?"

November 14, 2024

Neurogene has been on a huge run in 2024. That came to a halt after the company released trial results. But, the results may be better than the market thinks.

Via MarketBeat

Critical Insights From ACADIA Pharmaceuticals Analyst Ratings: What You Need To Know ↗

October 10, 2024

Via Benzinga

Expert Outlook: ACADIA Pharmaceuticals Through The Eyes Of 5 Analysts ↗

August 07, 2024

Via Benzinga

A Closer Look at 13 Analyst Recommendations For ACADIA Pharmaceuticals ↗

July 12, 2024

Via Benzinga

Expert Ratings For ACADIA Pharmaceuticals ↗

June 25, 2024

Via Benzinga

What's Going On With ACADIA Pharmaceuticals Stock? ↗

September 24, 2024

ACADIA Pharmaceuticals shares are trading lower by 4.6% during Tuesday's session. The company appointed Catherine Owen Adams as CEO.

Via Benzinga

Jim Cramer Believes In Dell CEO, Doesn't Like B&G Foods ↗

August 27, 2024

Cramer gives his take on E.l.f Beauty, Acadia Pharmaceuticals, B&G Foods, Lucid, SoFi, Dell, Johnson & Johnson, UWM and Symbotic.

Via Benzinga

Biotech Stocks: Why Acadia Pharma And Others Are Feeling 'Growing Pains' ↗

August 07, 2024

Acadia led a biotech selloff on Wednesday as Daybue sales missed expectations.

Via Investor's Business Daily

Topics Earnings

Airbnb Reports Weak Earnings, Joins Cryoport, Tripadvisor, Lyft And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

August 07, 2024

Via Benzinga

This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

June 27, 2024

Via Benzinga

Cracking The Code: Understanding Analyst Reviews For ACADIA Pharmaceuticals ↗

April 10, 2024

Via Benzinga

Expert Ratings For ACADIA Pharmaceuticals ↗

March 25, 2024

Via Benzinga

3 Sorry Pharma Stocks to Sell in May While You Still Can ↗

May 29, 2024

Discover three pharma stocks to sell in May while you still can. Avoid these companies facing significant setbacks.

Via InvestorPlace

After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February ↗

May 24, 2024

Cencora reports a cyberattack exposing sensitive medical information, including patient names, addresses, birth dates, diagnoses, and medications.

Via Benzinga

Topics Data Breach

Shhh! 3 Secret Penny Stocks Flying Below Wall Street’s Radar ↗

May 09, 2024

Under-the-radar penny stocks can be some of the most rewarding investments on the market. Here are three to consider.

Via InvestorPlace

ACAD Stock Earnings: ACADIA Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024 ↗

May 08, 2024

ACAD stock results show that ACADIA Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

ACADIA Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (25 Ratings) ↗

April 30, 2024

Via Benzinga

3 Pharma Stocks to Sell in April Before They Crash & Burn ↗

April 11, 2024

Discover three pharma stocks to sell in April, facing challenges and signaling potential for significant downside.

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

March 19, 2024

Via Benzinga

3 Pharma Stocks to Sell in March Before They Crash & Burn ↗

March 14, 2024

Discover top pharma stocks to sell in March before they plummet. Learn why ACAD, AMLX and WST are on the list for urgent sell-off decisions.

Via InvestorPlace

Why Are Airline Stocks Down Today? ↗

March 12, 2024

Airline stocks are down on Tuesday as investors deal with several bits of bad news for the industry on Tuesday!

Via InvestorPlace

Why Is Acadia Pharmaceuticals (ACAD) Stock Down 18% Today? ↗

March 12, 2024

Acadia Pharmaceuticals stock is falling on Tuesday as investors in ACAD react to its failed Phase 3 clinical trial of pimavanserin.

Via InvestorPlace

Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 12, 2024

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.

Via Benzinga

Oracle To Rally Around 40%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

March 12, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Acadia Hits 11-Month Low After Outsized Placebo Effect Torpedoes Schizophrenia Study ↗

March 12, 2024

The company says it doesn't plan to further develop Nuplazid in clinical testing.

Via Investor's Business Daily

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 12, 2024

Via Benzinga

Why Oracle Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗

March 12, 2024

Shares of Oracle Corporation (NYSE: ORCL) rose sharply in today’s pre-market trading after the company reported upbeat earnings for its fis

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

ACADIA Pharmaceuticals Inc. - Common Stock (NQ:ACAD)

Headline News about ACADIA Pharmaceuticals Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today